Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 1/2011

Ausgabe 1/2011

Inhaltsverzeichnis ( 34 Artikel )

01.02.2011 | Review | Ausgabe 1/2011

Gene signatures of breast cancer progression and metastasis

David I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, Ann F Chambers

01.02.2011 | Editorial | Ausgabe 1/2011

Appraisal of progenitor markers in the context of molecular classification of breast cancers

Izhak Haviv

01.02.2011 | Editorial | Ausgabe 1/2011

Chasing the immortal strand: evidence for nature's way of protecting the breast genome

Nikolajs Zeps, Christine Hemmings

01.02.2011 | Letter | Ausgabe 1/2011

Circulating microRNAs: promising breast cancer Biomarkers

Helen M Heneghan, Nicola Miller, Michael J Kerin

01.02.2011 | Letter | Ausgabe 1/2011

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib

Cristina Oliveras-Ferraros, Sílvia Cufí, Tamara Sauri-Nadal, Sonia Del Barco, Begoña Martin-Castillo, Alejandro Vazquez-Martin, Javier A Menendez

01.02.2011 | Editorial | Ausgabe 1/2011

3D culture reveals a signaling network

Senthil K Muthuswamy

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73

Richa Tiwary, Weiping Yu, Bob G Sanders, Kimberly Kline

01.02.2011 | Viewpoint | Ausgabe 1/2011

A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file

Whitney K Petrie, Russell C Hovey

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivotumor growth

Li Xu Yan, Qi Nian Wu, Yan Zhang, Yang Yang Li, Ding Zhun Liao, Jing Hui Hou, Jia Fu, Mu Sheng Zeng, Jing Ping Yun, Qiu Liang Wu, Yi Xin Zeng, Jian Yong Shao

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

Angelika Brekman, Kathryn E Singh, Alla Polotskaia, Nandini Kundu, Jill Bargonetti

01.02.2011 | Viewpoint | Ausgabe 1/2011

High hopes for RANKL: will the mouse model live up to its promise?

Tamara Tanos, Cathrin Brisken

01.02.2011 | Editorial | Ausgabe 1/2011

Breast cancer genome heterogeneity: a challenge to personalised medicine?

Charles Swanton, Rebecca A Burrell, P Andrew Futreal

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response

Tobias Hahn, Bhumasamudram Jagadish, Eugene A Mash, Kendra Garrison, Emmanuel T Akporiaye

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

Florence Le Calvez-Kelm, Fabienne Lesueur, Francesca Damiola, Maxime Vallée, Catherine Voegele, Davit Babikyan, Geoffroy Durand, Nathalie Forey, Sandrine McKay-Chopin, Nivonirina Robinot, Tù Nguyen-Dumont, Alun Thomas, Graham B Byrnes, John L Hopper, Melissa C Southey, Irene L Andrulis, Esther M John, Sean V Tavtigian, Breast Cancer Family Registry

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

Jean-Christophe Bourdon, Marie P Khoury, Alexandra Diot, Lee Baker, Kenneth Fernandes, Mustapha Aoubala, Philip Quinlan, Colin A Purdie, Lee B Jordan, Anne-Catherine Prats, David P Lane, Alastair M Thompson

01.02.2011 | Letter | Ausgabe 1/2011

Circulating microRNAs: promising breast cancer biomarkers - authors' response

Carina Roth, Brigitte Rack, Volkmar Müller, Wolfgang Janni, Klaus Pantel, Heidi Schwarzenbach

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors

Jun J Mao, H Irene Su, Rui Feng, Michelle L Donelson, Richard Aplenc, Timothy R Rebbeck, Frank Stanczyk, Angela DeMichele

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Huiling Xu, Max Yan, Jennifer Patra, Rachael Natrajan, Yuqian Yan, Sigrid Swagemakers, Jonathan M Tomaszewski, Sandra Verschoor, Ewan KA Millar, Peter van der Spek, Jorge S Reis-Filho, Robert G Ramsay, Sandra A O'Toole, Catriona M McNeil, Robert L Sutherland, Michael J McKay, Stephen B Fox

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

Yuqing Li, Yi Li, Sara Wedrén, Guoliang Li, Tze Howe Charn, Kartiki Vasant Desai, Carine Bonnard, Kamila Czene, Keith Humphreys, Hatef Darabi, Kristjana Einarsdóttir, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Kee Seng Chia, Heli Nevanlinna, Per Hall, Edison T Liu, Jianjun Liu

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer

Lisa M Arendt, Debra E Rugowski, Tara A Grafwallner-Huseth, Maria Jose Garcia-Barchino, Hallgeir Rui, Linda A Schuler

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen

Donal J Brennan, Henriette Laursen, Darran P O'Connor, Signe Borgquist, Mathias Uhlen, William M Gallagher, Fredrik Pontén, Robert C Millikan, Lisa Rydén, Karin Jirström

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry

Letitia D Smith, Andrea A Tesoriero, Ee M Wong, Susan J Ramus, Frances P O'Malley, Anna Marie Mulligan, Mary Beth Terry, Ruby T Senie, Regina M Santella, Esther M John, Irene L Andrulis, Hilmi Ozcelik, Mary B Daly, Andrew K Godwin, Saundra S Buys, Stephen Fox, David E Goldgar, Graham G Giles, John L Hopper, Melissa C Southey

01.02.2011 | Review | Ausgabe 1/2011

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

Caitlin D May, Nathalie Sphyris, Kurt W Evans, Steven J Werden, Wenjun Guo, Sendurai A Mani

01.02.2011 | Review | Ausgabe 1/2011

Do aromatase inhibitors have adverse effects on cognitive function?

Kelly Anne Phillips, Karin Ribi, Richard Fisher

01.02.2011 | Review | Ausgabe 1/2011

Functional magnetic resonance: biomarkers of response in breast cancer

Elizabeth AM O'Flynn, Nandita M deSouza

01.02.2011 | Letter | Ausgabe 1/2011

Mutation screening of RAD51C in male breast cancer patients

Valentina Silvestri, Piera Rizzolo, Mario Falchetti, Ines Zanna, Giovanna Masala, Domenico Palli, Laura Ottini

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice

Maha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, Veronique Garambois, Sebastien Morisseau, Bruno Robert, Caroline Bascoul-Mollevi, Imade Ait Arsa, William Jacot, Jean-Pierre Pouget, Andre Pelegrin, Isabelle Navarro-Teulon

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein

Marcela D Salazar, Maya Ratnam, Mugdha Patki, Ivana Kisovic, Robert Trumbly, Mohamed Iman, Manohar Ratnam

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

Pierre-Jean Lamy, Frédéric Fina, Caroline Bascoul-Mollevi, Anne-Claire Laberenne, Pierre-Marie Martin, L'Houcine Ouafik, William Jacot

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression

Peter Chan, Andreas Möller, Mira CP Liu, Jaclyn E Sceneay, Christina SF Wong, Nic Waddell, Katie T Huang, Alexander Dobrovic, Ewan KA Millar, Sandra A O'Toole, Catriona M McNeil, Robert L Sutherland, David D Bowtell, Stephen B Fox

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals

Kirsi M Kuusisto, Aleksandra Bebel, Mauno Vihinen, Johanna Schleutker, Satu-Leena Sallinen

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway

Samir Ounzain, Samantha Bowen, Chandrakant Patel, Rieko Fujita, Richard J Heads, Vishwanie S Budhram-Mahadeo

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development

Jyh-Cherng Yu, Chia-Ni Hsiung, Huan-Ming Hsu, Bo-Ying Bao, Shou-Tung Chen, Giu-Cheng Hsu, Wen-Cheng Chou, Ling-Yueh Hu, Shian-Ling Ding, Chun-Wen Cheng, Pei-Ei Wu, Chen-Yang Shen

01.02.2011 | Research article | Ausgabe 1/2011 Open Access

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

Stephen B Fox, Daniele Generali, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Teresa Mele, Luigi Dogliotti, Alberto Bottini, Adrian L Harris

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise